PMID- 23886643 OWN - NLM STAT- MEDLINE DCOM- 20140624 LR - 20131106 IS - 1422-6421 (Electronic) IS - 1422-6405 (Linking) VI - 198 IP - 2 DP - 2013 TI - Bone marrow mononuclear cell transplantation increases metalloproteinase-9 and 13 and decreases tissue inhibitors of metalloproteinase-1 and 2 expression in the liver of cholestatic rats. PG - 139-48 LID - 10.1159/000353215 [doi] AB - Liver fibrosis results from chronic injury followed by activation of macrophages and fibrogenic cells like myofibroblasts and activated hepatic stellate cells. These fibrogenic cells express alpha-smooth muscle actin (alpha-SMA) and produce excessive extracellular matrix (ECM), with disorganization and loss of function of hepatic parenchyma. It is known that increased levels of metalloproteinases (MMPs) in liver fibrosis are associated with reduction of the pathologic ECM and fibrosis resolution. Recently, it has been shown that bone marrow mononuclear cells (BMMNCs) may reduce collagen and alpha-SMA expression, and ameliorate liver function in cholestatic rats. Therefore, this study aimed to analyze MMP-2, MMP-9 and MMP-13, and tissue inhibitors of MMPs (TIMPs)-1 and TIMP-2 in the liver of cholestatic rats transplanted with BMMNC. Animals were divided into normal rats, cholestatic rats obtained after 14 and 21 days of bile duct ligation (BDL), and rats obtained after 14 days of BDL that received BMMNCs and were killed after 7 days. MMP and TIMP expression was assessed by Western blotting, along with alpha-SMA, CD68 and CD11b expression by confocal microscopy. Western blotting analysis showed that 14-day BDL animals had significantly reduced amounts of MMP-2 and MMP-13, but increased amounts of MMP-9 compared to normal rats. After 21 days of BDL, overall MMP amounts were decreased and TIMPs were increased. BMMNC transplantation significantly increased MMP-9 and MMP-13, and decreased TIMP expression. Increased MMP activity was confirmed by zymography. MMP-9 and MMP-13 were expressed by macrophages near fibrotic septa, suggesting BMMNC may stimulate MMP production in fibrotic livers, contributing to ECM degradation and hepatic regeneration. CI - (c) 2013 S. Karger AG, Basel. FAU - Nunes de Carvalho, Simone AU - Nunes de Carvalho S AD - Laboratorio Cultura de Celulas, Departamento de Histologia e Embriologia, Instituto de Biologia, Universidade do Estado do Rio de Janeiro, UERJ, Rio de Janeiro, Brazil. FAU - Helal-Neto, Edward AU - Helal-Neto E FAU - de Andrade, Daniela Caldas AU - de Andrade DC FAU - Costa Cortez, Erika Afonso AU - Costa Cortez EA FAU - Thole, Alessandra Alves AU - Thole AA FAU - Barja-Fidalgo, Christina AU - Barja-Fidalgo C FAU - de Carvalho, Lais AU - de Carvalho L LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20130724 PL - Switzerland TA - Cells Tissues Organs JT - Cells, tissues, organs JID - 100883360 RN - 0 (Tissue Inhibitor of Metalloproteinase-1) RN - 127497-59-0 (Tissue Inhibitor of Metalloproteinase-2) RN - EC 3.4.24.- (Matrix Metalloproteinase 13) RN - EC 3.4.24.24 (Matrix Metalloproteinase 2) RN - EC 3.4.24.35 (Matrix Metalloproteinase 9) SB - IM MH - Animals MH - Blotting, Western MH - Bone Marrow Cells MH - *Bone Marrow Transplantation MH - Cholestasis/*enzymology/pathology/therapy MH - Fluorescent Antibody Technique MH - Liver/*enzymology/pathology MH - Male MH - Matrix Metalloproteinase 13/*metabolism MH - Matrix Metalloproteinase 2/metabolism MH - Matrix Metalloproteinase 9/*metabolism MH - Microscopy, Confocal MH - Rats MH - Rats, Wistar MH - Tissue Inhibitor of Metalloproteinase-1/*metabolism MH - Tissue Inhibitor of Metalloproteinase-2/*metabolism EDAT- 2013/07/28 06:00 MHDA- 2014/06/25 06:00 CRDT- 2013/07/27 06:00 PHST- 2013/05/21 00:00 [accepted] PHST- 2013/07/27 06:00 [entrez] PHST- 2013/07/28 06:00 [pubmed] PHST- 2014/06/25 06:00 [medline] AID - 000353215 [pii] AID - 10.1159/000353215 [doi] PST - ppublish SO - Cells Tissues Organs. 2013;198(2):139-48. doi: 10.1159/000353215. Epub 2013 Jul 24.